Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis

被引:898
作者
Tang, Benjamin M. P.
Eslick, Guy D.
Nowson, Caryl
Smith, Caroline
Bensoussan, Alan
机构
[1] Univ Sydney, Nepean Hosp, Western Clin Sch, Penrith, NSW 2751, Australia
[2] Univ Western Sydney, Ctr Complementary Med Res, Sydney, NSW, Australia
[3] Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic 3217, Australia
关键词
D O I
10.1016/S0140-6736(07)61342-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Whether calcium supplementation can reduce osteoporotic fractures is uncertain. We did a meta-analysis to include all the randomised trials in which calcium, or calcium in combination with vitamin D, was used to prevent fracture and osteoporotic bone loss. Methods We identified 29 randomised trials (n=63897) using electronic databases, supplemented by a hand-search of reference lists, review articles, and conference abstracts. All randomised trials that recruited people aged 50 years or older were eligible. The main outcomes were fractures of all types and percentage change of bone-mineral density from baseline. Data were pooled by use of a random-effect model. Findings In trials that reported fracture as an outcome (17 trials, n=52625), treatment was associated with a 12% risk reduction in fractures of all types (risk ratio 0 center dot 88, 95% CI 0 center dot 83 center dot 0 center dot 95; p=O center dot 0004). In trials that reported bone-mineral density as an outcome (23 trials, n=41 419), the treatment was associated with a reduced rate of bone loss of 0 center dot 54% (0 center dot 3 5-0 center dot 73; p < O center dot 0001) at the hip and 1 center dot 19% (0 center dot 76-1 center dot 61%; p < O center dot 0001) in the spine. The fracture risk reduction was significantly greater (24%) in trials in which the compliance rate was high (p < O center dot 0001). The treatment effect was better with calcium doses of 1200 mg or more than with doses less than 1200 mg (0 center dot 80 vs 0 center dot 94; p=O.006), and with vitamin D doses of 800 IU or more than with doses less than 800 IU (0 center dot 84 vs 0 center dot 87; p=O.03). Interpretation Evidence supports the use of calcium, or calcium in combination with vitamin D supplementation, in the preventive treatment of osteoporosis in people aged 50 years or older. For best therapeutic effect, we recommend minimum doses of 1200 mg of calcium, and 800 IU of vitamin D (for combined calcium plus vitamin D supplementation).
引用
收藏
页码:657 / 666
页数:10
相关论文
共 53 条
[31]   PROGRESSIVE LOSS OF BONE IN THE FEMORAL-NECK IN ELDERLY PEOPLE - LONGITUDINAL FINDINGS FROM THE DUBBO OSTEOPOROSIS EPIDEMIOLOGY STUDY [J].
JONES, G ;
NGUYEN, T ;
SAMBROOK, P ;
KELLY, PJ ;
EISMAN, JA .
BRITISH MEDICAL JOURNAL, 1994, 309 (6956) :691-695
[32]   BONE-MINERAL CONTENT IN WOMEN WITH COLLES FRACTURE - EFFECT OF CALCIUM SUPPLEMENTATION [J].
LAMKE, B ;
SJOBERG, HE ;
SYLVEN, M .
ACTA ORTHOPAEDICA SCANDINAVICA, 1978, 49 (02) :143-146
[33]   Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: A pragmatic population-based 3-year intervention study [J].
Larsen, ER ;
Mosekilde, L ;
Foldspang, A .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (03) :370-378
[34]   THE EFFECTS OF CALCIUM SUPPLEMENTATION AND EXERCISE ON BONE-DENSITY IN ELDERLY CHINESE WOMEN [J].
LAU, EMC ;
WOO, J ;
LEUNG, PC ;
SWAMINATHAN, R ;
LEUNG, D .
OSTEOPOROSIS INTERNATIONAL, 1992, 2 (04) :168-173
[35]   CUMULATIVE METAANALYSIS OF CLINICAL-TRIALS - BUILDS EVIDENCE FOR EXEMPLARY MEDICAL-CARE [J].
LAU, J ;
SCHMID, CH ;
CHALMERS, TC .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (01) :45-57
[36]   Calcium-vitamin D3 supplementation is cost-effective in hip fractures prevention [J].
Lilliu, H ;
Pamphile, R ;
Chapuy, MC ;
Schulten, J ;
Arlot, M ;
Meunier, PJ .
MATURITAS, 2003, 44 (04) :299-305
[37]   Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss:: A randomized controlled open-label prospective trial [J].
Meier, C ;
Woitge, HW ;
Witte, K ;
Lemmer, B ;
Seibel, MJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (08) :1221-1230
[38]   Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement [J].
Moher, D ;
Cook, DJ ;
Eastwood, S ;
Olkin, I ;
Rennie, D ;
Stroup, DF .
LANCET, 1999, 354 (9193) :1896-1900
[39]  
Orwin R. G., 1983, Journal of Educational Statistics, V8, P157, DOI [10.3102/10769986008002157, DOI 10.3102/10769986008002157, 10.2307/1164923, DOI 10.2307/1164923]
[40]   THE RATE OF BONE-MINERAL LOSS IN NORMAL MEN AND THE EFFECTS OF CALCIUM AND CHOLECALCIFEROL SUPPLEMENTATION [J].
ORWOLL, ES ;
OVIATT, SK ;
MCCLUNG, MR ;
DEFTOS, LJ ;
SEXTON, G .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (01) :29-34